A nephrologist outlines gaps in CKD tracking, medication access, and transplant standards across the carceral health system.

Maursetter LJ. Nephrology care for incarcerated people: a call to action. 

https://www.nature.com/articles/s41581-026-01108-7

CKD Care Gaps for Incarcerated Patients, With Laura Maursetter, MD. HCPLive. Published August 25, 2026. 

https://www.hcplive.com/view/ckd-care-gaps-for-incarcerated-patients-with-laura-maursetter-md

Closing the Gaps in CKD Screening, Transplant Access, and Education for Incarcerated Patients. HCPLive. Published August 29, 2026. 

https://www.hcplive.com/view/closing-the-gaps-in-ckd-screening-transplant-access-and-education-for-incarcerated-patients

Articles

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

News

news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.

Nephrology

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Chronic Kidney Disease

For Incarcerated Patients, Kidney Care Can't Wait, With Laura Maursetter, MD

Mahboobeh Mahdavinia, MD, PhD, a board-certified allergist/immunologist from The University of Texas Health Science Center at Houston

 carries some chance of resolution, even peanut allergy, historically considered unlikely to resolve, according to Mahboobeh Mahdavinia, MD, PhD, a board-certified allergist/immunologist from The University of Texas Health Science Center at Houston.¹ Mahdavinia said the message for practicing allergists is straightforward: discuss the possibility of resolution at diagnosis regardless of allergen, and recheck IgE levels or offer an oral food challenge at least yearly, since a year or 2 of surveillance can change a family's dietary reality.

Egg Ladder Protocol Remains Underused Despite Safety Data

Mahdavinia said early, unpublished follow-up data from a subset of the FORWARD cohort suggest yearly surveillance may meaningfully raise peanut resolution rates above the 3.8% seen at initial enrollment, though the finding has not yet been published or peer-reviewed. The latest FORWARD data reported that resolution rates varied greatly by allergen: 35% for milk, 32% for soy, 27% for wheat, 3.8% for peanut, and 3.5% for shellfish. 

The analysis also identified socioeconomic and racial disparities in food allergies, with resolution lower in Black or Hispanic children and children with lower household income, lower parental health literacy scores, and higher area deprivation index. 

A separate area of focus for Mahdavinia's group is an egg ladder protocol being presented as an abstract at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) conference in Pheonix. She said the graded, at-home introduction protocol is published and freely available but rarely used in practice, largely because of the counseling burden it places on clinicians and families.

"It's not a pill to prescribe. It's lots of talking," Mahdavinia said.

The first visit alone can take close to an hour, she said, and providers need full confidence in the protocol before introducing it, since hesitancy is easily picked up by anxious parents managing reactions at home.

Mahdavinia said her group is preparing 6 additional food-specific resolution papers covering milk, egg, fish, shellfish, and tree nut allergy, alongside milk and egg ladder abstracts for the same AAAAI meeting. FORWARD is led by principal investigator Ruchi Gupta, MD, with Mahdavinia serving as a site PI.²

“This [FORWARD] project is really working on how to help [the] resolution of food allergy,” Mahdavinia said. “We are grateful to [Gupta] for her leadership. That's why we can get to do all these beautiful studies.”

Socioeconomic, Racial Disparities Linked to Food Allergy Resolution

Racial Gap in Food Allergy Resolution Traced to Access, Not Biology

Closing the Food Allergy Resolution Gap Needs More Than Specialist Access

Editor’s note: Reported disclosures for Mahdavinia include Eli Lilly and Company, GENZYME CORPORATION, Blueprint Medicines Corporation, Regeneron Healthcare Solutions, AstraZeneca Pharmaceuticals LP, Takeda Pharmaceuticals U.S.A., Inc., Grifols USA, CSL Behring, Pharming Healthcare, Inc., Novartis Pharmaceuticals Corporation, and Paratek Pharmaceuticals.

Dileep A, Bilaver LA, Warren C, et al. Factors associated with outgrowing food allergies: insights from a large food allergy cohort. 

Derman C. Race, income, and health literacy tied to food allergy resolution. HCPLive. Published August 17, 2026. Accessed August 31, 2026. 

https://www.hcplive.com/view/race-income-health-literacy-food-allergy-resolution

Videos

Mahboobeh Mahdavinia, MD, says a published, safe at-home protocol for resolving egg allergy is rarely used because of the counseling time it demands.

Allergy

Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Food Allergy

, held August 29-30 in Newport Beach, California, Peter Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine and founding director of the Chicago Integrative Eczema Center, previewed his session introducing Skin Angels, the Strategic Knowledge and Investment Network Group.

The group brings together dermatologists and other skin-space experts to evaluate early-stage companies with founders pitching for advice, connections, and early angel investment.

Skin Angels and the Atopic Dermatitis Pipeline, With Peter Lio, MD

Skin Angels has been operating for close to two years, according to Lio. More than 300 companies have presented to the group, and members have funded more than 30 of them, spanning over-the-counter products, drugs, and devices. Dermatologist Manju Dawkins, MD, founder of Thimble Health, also spoke with HCPLive at the meeting about her own path into the group.1

"If you ask your financial advisor, they would say this is crazy, don't do it. It's not about making money. That would be an amazing side effect if we can have some big successes and share that with the founders, but really it's about shaping the world of dermatology and ultimately shaping the world around us," Lio said.

Lio said interest in dermatology-specific investing has grown as more clinicians launch their own product lines, software, and services, an ecosystem he said the tech industry already has through its own venture-capital networks. His session includes short pitches from a few Skin Angels companies, giving attendees a sense of what it feels like to evaluate a founder and decide whether to invest.

Lio said the group's central thesis is even modest support, whether encouragement, networking, or capital, can meaningfully help a promising idea take shape. He described the mission as identifying good people with strong ideas early and helping them succeed.

Beyond Skin Angels, Lio also spoke about where he sees momentum in atopic dermatitis. He highlighted an oral agent in early development designed to work through the same interleukin-4 and interleukin-13 pathways as existing biologics, along with a topical botanical agent carrying antimicrobial and anti-inflammatory effects.

He also pointed to a new lab test intended to help clinicians choose between a JAK inhibitor and a T-helper-2-focused biologic. Lio said the test marks an early but meaningful step toward precision dermatology, though he does not consider it ready for routine practice yet.

Editor's Note: This transcript has been edited for grammar and clarity using artificial intelligence tools. Lio had no relevant disclosures of note.

Dawkins M. Why Dermatologists Should Have a Seat at the Investment Table, With Manju Dawkins, MD. HCPLive. August 30, 2026. Accessed August 31, 2026. 

https://www.hcplive.com/view/why-dermatologists-should-have-seat-investment-table-manju-dawkins-md

LEADderm. About LEADderm: the missing curriculum. leadderm.org.

Peter Lio, MD, on Skin Angels, a dermatology-focused angel-investing group that has evaluated over 300 companies and funded more than 30.

Atopic Dermatitis

Atopic Dermatitis condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Conference

 conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.

Hilary Ugras, NP, is a nurse practitioner in GI motility at Beth Israel Deaconess Medical Center.

Accurate EoE diagnosis requires more than recognizing symptoms. The expert faculty highlight how clinical suspicion, appropriate biopsy sampling, histology, and endoscopic findings come together to establish a confident diagnosis.

Establishing a Confident EoE Diagnosis

In this episode, ‘Establishing a Confident EoE Diagnosis,’ the expert advanced practice providers explore the clinical and diagnostic considerations that support accurate identification of eosinophilic esophagitis (EoE). The panel discusses when symptoms such as dysphagia, food impaction, longstanding adaptive eating behaviors, and atopic comorbidities should prompt referral for endoscopic evaluation with esophageal biopsies. They emphasize the important role of communication between advanced practice providers and endoscopists to ensure that the clinical suspicion for EoE is clearly conveyed and appropriate biopsies are obtained, even when the esophagus appears normal.

The panelists also highlight patient education as an important part of the diagnostic process, particularly in helping patients understand why endoscopic evaluation may still be necessary despite previously normal imaging or other testing. They then review the components of a confident EoE diagnosis, including symptoms of esophageal dysfunction, appropriate biopsy sampling, and the histologic threshold of at least 15 eosinophils per high-power field. The expert faculty discuss recommendations to obtain multiple biopsies from different levels of the esophagus to improve diagnostic accuracy.

Finally, the panel examines how clinical presentation, endoscopic findings, and histology can help differentiate EoE from other potential causes of esophageal eosinophilia, particularly gastroesophageal reflux disease. They also discuss the value of standardized endoscopic assessment, including the EoE Endoscopic Reference Score, for establishing a baseline that can support evaluation throughout the patient journey.

The next episode in this series, ‘The Importance of Early Diagnosis in EoE,

 features the panelists discussing how diagnostic delays and persistent inflammation can contribute to progressive esophageal remodeling and fibrostenotic complications. They also share practical strategies for helping patients understand the importance of early diagnosis and disease control.

Video Series

EoE does not always present as straightforward dysphagia. The panel explores how adaptive eating behaviors, age-specific presentations, atopic comorbidities, and food impaction can provide critical clues for earlier recognition and diagnosis.

Recognizing EoE Across Pediatric and Adult Patients

Welcome back to another HCPLive Peer Exchange series. In this episode titled, “Recognizing EoE Across Pediatric and Adult Patients,” expert faculty examine the symptoms, eating behaviors, and comorbidities that can raise suspicion for eosinophilic esophagitis (EoE) and discuss how clinical presentation can differ by age.

The panel highlights dysphagia as a hallmark symptom of EoE in adults while emphasizing that patients may not describe swallowing difficulty directly. Instead, clinicians may uncover adaptive eating behaviors, such as cutting food into small pieces, avoiding certain textures, using liquids to help food pass, or having difficulty swallowing pills. In pediatric patients, EoE may present differently, with abdominal pain, failure to thrive, nutritional deficiencies, food refusal, or texture preferences. The panel also discusses the importance of assessing for associated type 2 inflammatory conditions, including food allergies, atopic dermatitis, asthma, and allergic rhinitis.

As recognition of EoE has increased, the panelists describe adopting a more proactive approach to patients with dysphagia or GERD-like symptoms, including maintaining a high index of suspicion and considering earlier endoscopic evaluation with biopsy. They also examine food impaction as an important presentation of EoE and explain why a detailed history can uncover previous episodes of food sticking that patients may have normalized. The discussion concludes by emphasizing the importance of obtaining biopsies during endoscopy for food impaction when appropriate, helping establish an EoE diagnosis while reducing the potential for patients to be lost to follow-up.

The next episode in this series, ‘Establishing a Confident EoE Diagnosis,’ features the panelists discussing when suspected EoE warrants endoscopic evaluation and biopsy and the clinical, histologic, and endoscopic findings needed to support an accurate diagnosis. The panel also explores differentiating EoE from other causes of esophageal eosinophilia and the importance of collaboration across the care team.

Alex Hillenbrand is an assistant editor for 

. She earned her BA in English from Lafayette College in 2023 and went on to write for pop culture, entertainment, and sports media outlets before joining MJH Life Sciences in 2025. In her free time, Alex enjoys cooking, going on walks, and meeting new people. Contact her at mjhlifesciences.com.

New RCT finds ketogenic diet cuts liver fat and improves glycemic control more than Mediterranean or plant-forward diets after matched weight loss. 

Hepatology

Ketogenic Diet Offers Liver Benefits Beyond Weight Loss Alone

Arjan Bredenoord, MD, gastroenterologist and professor, Amsterdam University Medical Center.

Arjan Bredenoord, MD, details how tezepelumab's selective TSLP inhibition sustained EoE remission through week 52 of the CROSSING trial.

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Tezepelumab's TSLP Blockade May Address Refractory EoE Gap

Steven Daveluy, MD, speaks on why dermatologists belong on social media, avoiding burnout in practice, and what excites him in HS treatment.

Reaching Patients Online and Avoiding Burnout, With Steven Daveluy, MD

Saakshi Khattri, MD, is a board certified Dermatologist, Rheumatologist and Internist and one of only a handful of triple board-certified physicians across the US.

"The Patient Who Is Better but Not Clear: Shared Decisions in Psoriasis" takes up the common scenario of a patient content with partial improvement.

The Patient Who Is Better but Not Clear: Shared Decisions in Psoriasis

In "Putting On-Treatment Remission Into Practice: A Patient-Defined Target in Psoriasis," the panel returns to remission and grounds it in what patients actually live with.

Putting On-Treatment Remission Into Practice: A Patient-Defined Target in Psoriasis

Ryan Livingston joined the MJH Life Sciences team in March of 2025, shortly after graduating from TCNJ with a bachelor’s degree in English. He enjoys creative writing, reading, and scuba diving. He can be reached at rlivingston@mjhlifesciences.com.

The investigational therapy did not achieve statistical significance in KCCQ-TSS or in 6MWD, but saw substantial changes in exploratory secondary endpoints.

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Heart Failure

The HCPLive heart failure page is a resource for medical news and expert insights on HF. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for heart disease, reduced and preserved ejection fraction, and more.

Hypertension

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.

LEVEL: Levosimendan Fails to Improve Exercise Limitations, Betters NT-proBNP and RVSP

Abigail Brooks is a strategic content lead overseeing 

She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.

H-ISDN missed its primary endpoint in H-HeFT, but a pooled meta-analysis found significant reductions in all-cause and cardiovascular death in HFrEF.

Hydralazine-Isosorbide Dinitrate Misses Endpoint in H-HeFT Trial

Christie Ballantyne, MD, unpacks SHASTA-3/4 results on plozasiran for severe hypertriglyceridemia, from triglyceride reduction to pancreatitis prevention.

Dyslipidemia

SHASTA-3/4: What an 80% Triglyceride Cut Means, With Christie Ballantyne, MD

The China Rural Hypertension Control Program found a non-physician-led intensive blood pressure intervention reduced dementia risk by 15% over 7 years.

Dementia and Alzheimer Disease

Alzheimer Disease condition center page, resources on the topics of medical news and expert insight into Alzheimer's can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dementa and Alzheimer disease research, treatment, and drug development.

Geriatrics

Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.

Intensive BP Control Cuts Dementia Risk By 15% in CRHCP Trial

Manju Dawkins, MD, is a board-certified dermatologist and entrepreneur based in the Los Angeles area who founded Thimble Health.

A dermatologist-turned-entrepreneur on why clinicians belong in dermatology's investment decisions, and what excites her about the field's direction.

Latest News

For Incarcerated Patients, Kidney Care Can't Wait, With Laura Maursetter, MD

Egg Ladder Protocol Remains Underused Despite Safety Data

Skin Angels and the Atopic Dermatitis Pipeline, With Peter Lio, MD

Establishing a Confident EoE Diagnosis

Recognizing EoE Across Pediatric and Adult Patients